Aldeyra Therapeutics, Inc. — Form D

Aldeyra Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-05. The offering totals $4.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Todd C BradyDirectorCRANBURY, NJ
C.Boyd C ClarkeDirectorLexington, MA
Todd C BradyExecutive OfficerCRANBURY, NJ
Stephen C TulipanoExecutive OfficerLexington, MA
Scott C YoungExecutive OfficerLexington, MA
Gerald CagleDirectorFort Worth, TX
Gerald CagleExecutive OfficerFort Worth, TX
Asish XavierDirectorSouth San Francisco, CA
Gary PhillipsDirectorNewton, MA
Todd BradyDirectorAtlanta, GA
Todd BradyExecutive OfficerAtlanta, GA
David L ClarkExecutive OfficerFortville, IN
Richard I DouglasDirectorLexington, MA
Neal J WalkerDirectorLexington, MA
Martin J JoyceDirectorLexington, MA
Ben J BronsteinDirectorLexington, MA
David L McMullinExecutive OfficerLexington, MA
Gary J PhillipsDirectorLexington, MA
Stephen I MachathaExecutive OfficerLexington, MA
Joshua ReedExecutive OfficerLexington, MA
Ben BronsteinDirectorWestborough, MA
Scott L YoungExecutive OfficerLexington, MA
C. Boyd L ClarkeDirectorLexington, MA
John DowlingDirectorBurlington, MA
Jesse I TreuDirectorPrinceton, NJ

Other filings by this issuer (3)

FiledFormOfferingSold
2019-02-11D$25.0M$10.0M
2015-01-29D$18.4M$7.8M
2013-01-03D$8.8M$4.8M

More